Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 15/20 | 0.54 |
| ▸ | DAO | P14920 | 1/20 | 0.43 |
| ▸ | HCAR3 | P49019 | 3/20 | 0.40 |
| ▸ | CYTH3 | O43739 | 1/20 | 0.40 |
| ▸ | BTK | Q06187 | 1/20 | 0.40 |
| ▸ | EPN1 | Q9Y6I3 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14586657 | 0.78 | HCAR2 (0.63) | HCAR2DAOHCAR3CYTH3BTK | |
| SCHEMBL5599558 | 0.78 | HCAR2 (0.63) | HCAR2DAOHCAR3CYTH3BTK | |
| SCHEMBL5599559 | 0.78 | HCAR2 (0.63) | HCAR2DAOHCAR3CYTH3BTK | |
| SCHEMBL21810960 | 0.71 | HCAR2 (1.00) | HCAR2DAOHCAR3CYTH3BTK | |
| SCHEMBL5599209 | 0.67 | HCAR2 (0.63) | HCAR2DAOHCAR3CYTH3BTK | |
| SCHEMBL14586656 | 0.67 | HCAR2 (0.63) | HCAR2DAOHCAR3CYTH3BTK | |
| SCHEMBL5599204 | 0.67 | HCAR2 (0.63) | HCAR2DAOHCAR3CYTH3BTK | |
| SCHEMBL5610945 | 0.65 | HCAR2 (0.54) | HCAR2DAOHCAR3MEN1KMT2A | |
| SCHEMBL5610946 | 0.65 | HCAR2 (0.54) | HCAR2DAOHCAR3MEN1KMT2A | |
| SCHEMBL165390 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119212697-A | Novel extension functionalization strategy for water-collecting MOF | 加利福尼亚大学董事会 | 2024-12-27 | — | — | CN | disclosed |